Use of 2-[125I]iodomelatonin to characterize melatonin binding sites in chicken retina

M. L. Dubocovich, J. S. Takahashi

Research output: Contribution to journalArticle

223 Citations (Scopus)

Abstract

2-[125I]Iodomelatonin binds with high affinity to a site possessing the pharmacological characteristics of a melatonin receptor in chicken retinal membranes. The specific binding of 2-[125I]iodomelatonin is stable, saturable, and reversible. Saturation experiments indicated that 2-[125I]iodomelatonin labeled a single class of sites with an affinity constant (K(d)) of 434 ± 56 pM and a total number of binding sites (B(max)) of 74.0 ± 13.6 fmol/mg of protein. The affinity constant obtained from kinetic analysis was in close agreement with that obtained in saturation experiments. Competition experiments showed a monophasic reduction of 2-[125I]iodomelatonin binding with a pharmacological order of indole amine affinities characteristic of a melatonin receptor: 2-iodomelatonin > 6-chloromelatonin ≥ melatonin ≥ 6,7-dichloro-2-methylmelatonin > 6-hydroxymelatonin ≥ 6-methoxymelatonin > N-acetyltryptamine > N-acetyl-5-hydroxytryptamine > 5-methoxytryptamine >>> 5-hydroxytryptamine (inactive). The affinities of these melatonin analogs in competing for 2-[125I]iodomelatonin binding sites were correlated closely with their potencies for inhibition of the calcium-dependent release of [3H]dopamine from chicken and rabbit retinas, indicating association of the binding site with a functional response regulated by melatonin. The results indicate that 2-[125I]iodomelatonin is a selective, high-affinity radioligand for the identification and characterization of melatonin receptor sites.

Original languageEnglish (US)
Pages (from-to)3916-3920
Number of pages5
JournalProceedings of the National Academy of Sciences of the United States of America
Volume84
Issue number11
StatePublished - 1987

Fingerprint

Melatonin
Retina
Chickens
Binding Sites
Melatonin Receptors
5-Methoxytryptamine
Pharmacology
2-iodomelatonin
Amines
Dopamine
Serotonin
Rabbits
Calcium
Membranes
Proteins

ASJC Scopus subject areas

  • General
  • Genetics

Cite this

@article{3acf2ff225b445879d007409fa80fc90,
title = "Use of 2-[125I]iodomelatonin to characterize melatonin binding sites in chicken retina",
abstract = "2-[125I]Iodomelatonin binds with high affinity to a site possessing the pharmacological characteristics of a melatonin receptor in chicken retinal membranes. The specific binding of 2-[125I]iodomelatonin is stable, saturable, and reversible. Saturation experiments indicated that 2-[125I]iodomelatonin labeled a single class of sites with an affinity constant (K(d)) of 434 ± 56 pM and a total number of binding sites (B(max)) of 74.0 ± 13.6 fmol/mg of protein. The affinity constant obtained from kinetic analysis was in close agreement with that obtained in saturation experiments. Competition experiments showed a monophasic reduction of 2-[125I]iodomelatonin binding with a pharmacological order of indole amine affinities characteristic of a melatonin receptor: 2-iodomelatonin > 6-chloromelatonin ≥ melatonin ≥ 6,7-dichloro-2-methylmelatonin > 6-hydroxymelatonin ≥ 6-methoxymelatonin > N-acetyltryptamine > N-acetyl-5-hydroxytryptamine > 5-methoxytryptamine >>> 5-hydroxytryptamine (inactive). The affinities of these melatonin analogs in competing for 2-[125I]iodomelatonin binding sites were correlated closely with their potencies for inhibition of the calcium-dependent release of [3H]dopamine from chicken and rabbit retinas, indicating association of the binding site with a functional response regulated by melatonin. The results indicate that 2-[125I]iodomelatonin is a selective, high-affinity radioligand for the identification and characterization of melatonin receptor sites.",
author = "Dubocovich, {M. L.} and Takahashi, {J. S.}",
year = "1987",
language = "English (US)",
volume = "84",
pages = "3916--3920",
journal = "Proceedings of the National Academy of Sciences of the United States of America",
issn = "0027-8424",
number = "11",

}

TY - JOUR

T1 - Use of 2-[125I]iodomelatonin to characterize melatonin binding sites in chicken retina

AU - Dubocovich, M. L.

AU - Takahashi, J. S.

PY - 1987

Y1 - 1987

N2 - 2-[125I]Iodomelatonin binds with high affinity to a site possessing the pharmacological characteristics of a melatonin receptor in chicken retinal membranes. The specific binding of 2-[125I]iodomelatonin is stable, saturable, and reversible. Saturation experiments indicated that 2-[125I]iodomelatonin labeled a single class of sites with an affinity constant (K(d)) of 434 ± 56 pM and a total number of binding sites (B(max)) of 74.0 ± 13.6 fmol/mg of protein. The affinity constant obtained from kinetic analysis was in close agreement with that obtained in saturation experiments. Competition experiments showed a monophasic reduction of 2-[125I]iodomelatonin binding with a pharmacological order of indole amine affinities characteristic of a melatonin receptor: 2-iodomelatonin > 6-chloromelatonin ≥ melatonin ≥ 6,7-dichloro-2-methylmelatonin > 6-hydroxymelatonin ≥ 6-methoxymelatonin > N-acetyltryptamine > N-acetyl-5-hydroxytryptamine > 5-methoxytryptamine >>> 5-hydroxytryptamine (inactive). The affinities of these melatonin analogs in competing for 2-[125I]iodomelatonin binding sites were correlated closely with their potencies for inhibition of the calcium-dependent release of [3H]dopamine from chicken and rabbit retinas, indicating association of the binding site with a functional response regulated by melatonin. The results indicate that 2-[125I]iodomelatonin is a selective, high-affinity radioligand for the identification and characterization of melatonin receptor sites.

AB - 2-[125I]Iodomelatonin binds with high affinity to a site possessing the pharmacological characteristics of a melatonin receptor in chicken retinal membranes. The specific binding of 2-[125I]iodomelatonin is stable, saturable, and reversible. Saturation experiments indicated that 2-[125I]iodomelatonin labeled a single class of sites with an affinity constant (K(d)) of 434 ± 56 pM and a total number of binding sites (B(max)) of 74.0 ± 13.6 fmol/mg of protein. The affinity constant obtained from kinetic analysis was in close agreement with that obtained in saturation experiments. Competition experiments showed a monophasic reduction of 2-[125I]iodomelatonin binding with a pharmacological order of indole amine affinities characteristic of a melatonin receptor: 2-iodomelatonin > 6-chloromelatonin ≥ melatonin ≥ 6,7-dichloro-2-methylmelatonin > 6-hydroxymelatonin ≥ 6-methoxymelatonin > N-acetyltryptamine > N-acetyl-5-hydroxytryptamine > 5-methoxytryptamine >>> 5-hydroxytryptamine (inactive). The affinities of these melatonin analogs in competing for 2-[125I]iodomelatonin binding sites were correlated closely with their potencies for inhibition of the calcium-dependent release of [3H]dopamine from chicken and rabbit retinas, indicating association of the binding site with a functional response regulated by melatonin. The results indicate that 2-[125I]iodomelatonin is a selective, high-affinity radioligand for the identification and characterization of melatonin receptor sites.

UR - http://www.scopus.com/inward/record.url?scp=0023353416&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0023353416&partnerID=8YFLogxK

M3 - Article

C2 - 3035559

AN - SCOPUS:0023353416

VL - 84

SP - 3916

EP - 3920

JO - Proceedings of the National Academy of Sciences of the United States of America

JF - Proceedings of the National Academy of Sciences of the United States of America

SN - 0027-8424

IS - 11

ER -